US Food and Drug Administration. New drugs at FDA: CDER’s new molecular entities and new therapeutic biological products. Accessed June 2, 2022. Available at: https://www.fda.gov/drugs/development-approval-process-drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products

• PubMed
US Food and Drug Administration. New drugs at FDA: CDER’s new molecular entities and new therapeutic biological products. Accessed June 2, 2022. Available at: https://www.fda.gov/drugs/development-approval-process-drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products)| false
• Search Google Scholar
• Export Citation

Mackler E, Segal EM, Muluneh B, et al. 2018 Hematology/Oncology Pharmacist Association best practices for the management of oral oncolytic therapy: pharmacy practice standard. J Oncol Pract 2019;15:e346–355.

• Crossref
• PubMed
Mackler E, Segal EM, Muluneh B, 2018 Hematology/Oncology Pharmacist Association best practices for the management of oral oncolytic therapy: pharmacy practice standard. J Oncol Pract 2019;15:e346–355.10.1200/JOP.18.0058130860937)| false
• Search Google Scholar
• Export Citation

Blinder VS, Garrett-Mayer E, Jacobson PB, et al. Oral chemotherapy metric performance in Quality Oncology Practice Initiative (QOPI) practices: updated trends and analysis. J Natl Compr Canc Netw 2022;20:1099–1106.

• PubMed
Blinder VS, Garrett-Mayer E, Jacobson PB, Oral chemotherapy metric performance in Quality Oncology Practice Initiative (QOPI) practices: updated trends and analysis. J Natl Compr Canc Netw 2022;20:1099–1106.)| false
• Search Google Scholar
• Export Citation

ASCO Practice Central. About QOPI certification. Accessed September 7, 2022. Available at: https://practice.asco.org/quality-improvement/quality-programs/qopi-certification-program/about-qopi-certification

• PubMed
ASCO Practice Central. About QOPI certification. Accessed September 7, 2022. Available at: https://practice.asco.org/quality-improvement/quality-programs/qopi-certification-program/about-qopi-certification)| false
• Search Google Scholar
• Export Citation

Neuss MN, Polovich M, McNiff K, et al. 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. J Oncol Pract 2013;9(2 Suppl):5s–13s.

• Crossref
• PubMed
Neuss MN, Polovich M, McNiff K, 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. J Oncol Pract 2013;9(2 Suppl):5s–13s.10.1200/JOP.2013.000874)| false
• Search Google Scholar
• Export Citation

Neuss M, Gilmore T, Belderson K, et al. 2016 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology. Oncol Nurs Forum 2017;44:31–43.

• Crossref
• PubMed
Neuss M, Gilmore T, Belderson K, 2016 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology. Oncol Nurs Forum 2017;44:31–43.10.1188/17.ONF.31-43)| false
• Search Google Scholar
• Export Citation

ASCO Practice Central. QOPI-related measures. Accessed September 8, 2022. Available at: https://practice.asco.org/quality-improvement/quality-programs/quality-oncology-practice-initiative/qopi-related-measures

• PubMed
ASCO Practice Central. QOPI-related measures. Accessed September 8, 2022. Available at: https://practice.asco.org/quality-improvement/quality-programs/quality-oncology-practice-initiative/qopi-related-measures)| false
• Search Google Scholar
• Export Citation

De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2003;2:323.

• Crossref
• PubMed
De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2003;2:323.10.1016/S1474-5151(03)00091-414667488)| false
• Search Google Scholar
• Export Citation

Muluneh B, Deal A, Alexander MD, et al. Patient perspectives on the barriers associated with medication adherence to oral chemotherapy. J Oncol Pharm Pract 2018;24:98–109.

• Crossref
• PubMed
Muluneh B, Deal A, Alexander MD, Patient perspectives on the barriers associated with medication adherence to oral chemotherapy. J Oncol Pharm Pract 2018;24:98–109.2789522010.1177/1078155216679026)| false
• Search Google Scholar
• Export Citation

Belcher SM, Mackler E, Muluneh B, et al. ONS Guidelines to support patient adherence to oral anticancer medications. Oncol Nurs Forum 2022;49:279–295.

• PubMed
Belcher SM, Mackler E, Muluneh B, ONS Guidelines to support patient adherence to oral anticancer medications. Oncol Nurs Forum 2022;49:279–295.35788731)| false
• Search Google Scholar
• Export Citation

Fernandez ME, Ruiter RAC, Markham CM, Kok G. Intervention mapping: theory- and evidence-based health promotion program planning: perspective and examples. Front Public Health 2019;7:209.

• Crossref
• PubMed
Fernandez ME, Ruiter RAC, Markham CM, Kok G. Intervention mapping: theory- and evidence-based health promotion program planning: perspective and examples. Front Public Health 2019;7:209.10.3389/fpubh.2019.0020931475126)| false
• Search Google Scholar
• Export Citation

Fernandez ME, Ten Hoor GA, van Lieshout S, et al. Implementation mapping: using intervention mapping to develop implementation strategies. Front Public Health 2019;7:158.

• Crossref
• PubMed
Fernandez ME, Ten Hoor GA, van Lieshout S, Implementation mapping: using intervention mapping to develop implementation strategies. Front Public Health 2019;7:158.10.3389/fpubh.2019.0015831275915)| false
• Search Google Scholar
• Export Citation